The Center for Macromolecular Interactions

The Center for Macromolecular Interactions (CMI) is primarily a shared instrument facility offering training and access on our technologies. The CMI offers the HMS community training and access to shared biophysical instruments for the characterization and analysis of macromolecules and their complexes. 

CMI News

CMI Binding Simulator

Check out the new Interactive CMI Tool for simulating equilibrium and kinetic binding experiments.

Recent CMI User Publications

  • CMI users agree to acknowledge the support of "the Center for Macromolecular Interactions at Harvard Medical School" in publications arising from use of the facility. CMI RRID: SCR_018270.
Ramesh, Anujan, Metecan Erdi, Shuyang Zhang, Vineeth Chandran Suja, Samir Mitragotri, and Bijay Singh. [2026] 2026. “Enhancing Bioavailability of Ultra-High Concentration Antibody Formulations Using Ionic Liquids.”. Advanced Healthcare Materials e71550. doi:10.1002/adhm.71550.
Ramesh, Anujan, Metecan Erdi, Shuyang Zhang, Vineeth Chandran Suja, Samir Mitragotri, and Bijay Singh. [2026] 2026. “Enhancing Bioavailability of Ultra-High Concentration Antibody Formulations Using Ionic Liquids.”. Advanced Healthcare Materials e71550. doi:10.1002/adhm.71550.
Inde, Zintis, Sebastian Keppler, Jesse Gelles, Cameron S Fraser, Adam Presser, Jarvier N Mohammed, May Jung, David S Garvey, Tudor Moldoveanu, Jerry E Chipuk, and Kristopher A Sarosiek. [2026] 2026. “A Peptide-Based Screen for Cell Death Inhibitors Identifies the Cytoprotective Compound CDL36.”. BioRxiv : The Preprint Server for Biology. doi:10.64898/2026.07.09.737573.
Inde, Zintis, Sebastian Keppler, Jesse Gelles, Cameron S Fraser, Adam Presser, Jarvier N Mohammed, May Jung, David S Garvey, Tudor Moldoveanu, Jerry E Chipuk, and Kristopher A Sarosiek. [2026] 2026. “A Peptide-Based Screen for Cell Death Inhibitors Identifies the Cytoprotective Compound CDL36.”. BioRxiv : The Preprint Server for Biology. doi:10.64898/2026.07.09.737573.
Sirimanakul, Suwitchaya, Joseph D. Hurley, Nakarin Vutipow, Fabien Loison, Anongnard Kasorn, Lueacha Tabtimmai, Pinpunya Riangrungroj, Jeerapond Leelawattanachai, Teetouch Ananwattanasuk, Napachanok Swainson, Kiattawee Choowongkomon, Andrew C. Kruse, and Dujduan Waraho-Zhmayev. [2026] 2026. “A Simple and Cost-Effective Electrochemical Assay for Heart Failure Prognosis Using Soluble Suppression of Tumorigenicity 2-Specific Nanobodies”. ACS Pharmacology & Translational Science. doi:10.1021/acsptsci.6c00082.
Sirimanakul, Suwitchaya, Joseph D. Hurley, Nakarin Vutipow, Fabien Loison, Anongnard Kasorn, Lueacha Tabtimmai, Pinpunya Riangrungroj, Jeerapond Leelawattanachai, Teetouch Ananwattanasuk, Napachanok Swainson, Kiattawee Choowongkomon, Andrew C. Kruse, and Dujduan Waraho-Zhmayev. [2026] 2026. “A Simple and Cost-Effective Electrochemical Assay for Heart Failure Prognosis Using Soluble Suppression of Tumorigenicity 2-Specific Nanobodies”. ACS Pharmacology & Translational Science. doi:10.1021/acsptsci.6c00082.

For information on access fees, policies and getting started at the CMI, see the CMI Access Page.